Category Archives: Corporate Responsibility

Takeda Changes Dexlansoprazole Brand Name From Kapidex to Dexilant

Takeda’s US subsidiary launched its proton pump inhibitor dexlansoprazole last February under the name Kapidex. No one thought they’d have to find a new name a year later. But shortly after the launch, the company began getting reports of dispensing errors. Some were due to prescription misreading, others to simple, honest mistakes. The two drugs causing [...]
Also posted in FDA, Marketing, News, Safety, Strategy | Tagged , , , , , , , , , , | 1 Comment

HBA Names Woman of the Year

GSK’s Deirdre Connelly has been named the Healthcare Businesswomen’s Association’s Woman of the Year for 2010. Connelly, who just passed the one-year mark as president of GSK’s North American pharmaceuticals unit, is the 21st woman to win the organization’s “WOTY” award, which comes on the heels of another honor: She was ranked #37 in Fortune’s [...]
Also posted in News, People, leadership | Tagged , , , , | Leave a comment

Pharma and Haiti: Can Altruism Backfire?

Guest blog by Pharm Exec Europe’s Jacky Law. Pharma companies are responding swiftly to the recent earthquake in Haiti with millions of dollars in cash and drugs. GlaxoSmithKline boasted, for example, that its initial $1.2 million offering of medicines — mainly oral and topical antibiotics — was on the first airlift to the Caribbean island and [...]
Also posted in Global, Guest Blog, News | Tagged , , , , , | Leave a comment

Witty Proposes Price Cap for Poor Nations

GlaxoSmithKline CEO Andrew Witty proposed Friday to slash drug prices in the world’s 50 poorest countries and reinvest 20 percent of the profits in bolstering local health care. In a speech at Harvard Medical School Friday, Witty said drug prices will be capped at 25 percent of what they cost in developed nations. He also [...]
Also posted in Emerging Markets, People | Tagged , , , | Leave a comment

Clinton Tinkers With Malaria Market

A team of reporters and camera crews packed into the headquarters of the Clinton Foundation on West 125th Street this afternoon to hear the details of former President Bill Clinton’s plan to tinker with the market for malaria drugs “in a way that has positive implications for the pharmaceutical companies,” he said.
Posted in Corporate Responsibility | Tagged , , , , , , , | 4 Comments